Capsid variants and methods of using the same
US-2024417430-A1 · Dec 19, 2024 · US
US8993228B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8993228-B2 |
| Application number | US-200913121914-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 30, 2009 |
| Priority date | Sep 30, 2008 |
| Publication date | Mar 31, 2015 |
| Grant date | Mar 31, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides an antibody that specifically binds to envelope protein 2 of HCV of genotype 2 a but does not immunologically react with envelope protein 2 of HCV of genotype 1 a .
Opening claim text (preview).
The invention claimed is: 1. An antibody, which specifically binds to envelope protein 2 of hepatitis C virus of genotype 2 a but does not immunologically react with envelope protein 2 of hepatitis C virus of genotype l a , wherein said antibody is produced by the hybridoma cell line having accession No. FERM BP-11181. 2. An antibody, which specifically binds to envelope protein 2 of hepatitis C virus of genotype 2 a but does not immunologically react wi…
Chemistry & Metallurgy · mapped topic
Physics · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Physics · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.